Back

PRState: Incorporating Genetic Ancestry in Prostate Cancer Risk scores for African American Men

Pagadala, M.; Linscott, J. A.; Talwar, J.; Seibert, T.; Rose, B.; Lynch, J.; Panizzon, M. S.; Hauger, R.; Hansen, M. H.; Sammon, J. D.; Hayn, M. H.; Kader, K.; Carter, H. K.; Ryan, S. T.

2022-03-13 oncology
10.1101/2022.03.12.22271020
Show abstract

Prostate cancer (PrCa) is one of the most genetically driven solid cancers with heritability estimates as high as 57%. African American men are at an increased risk of PrCa; however, current risk prediction models are based on European ancestry groups and may not be broadly applicable. In this study, we define an African ancestry group of 4,533 individuals to develop an African ancestry-specific PrCa polygenic risk score (PRState). We identified risk loci on chromosomes 3, 8, and 11 in the African ancestry group GWAS and constructed a polygenic risk score (PRS) from 10 African ancestry-specific PrCa risk SNPs, achieving an AUC of 0.61 [0.60-0.63] and 0.65 [0.64-0.67], when combined with age and family history. Performance dropped significantly when using ancestry-mismatched PRS models but remained comparable when using trans-ancestry models. Importantly, we validated the PRState score in the Million Veteran Program, demonstrating improved prediction of PrCa and metastatic PrCa in African American individuals. This study underscores the need for inclusion of individuals of African ancestry in gene variant discovery to optimize PRS.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Nature Communications
based on 483 papers
Top 7%
11.1%
2
Cancer Epidemiology, Biomarkers & Prevention
based on 14 papers
Top 0.1%
11.0%
3
eLife
based on 262 papers
Top 3%
5.3%
4
Cancer Medicine
based on 17 papers
Top 0.5%
5.0%
5
Cancers
based on 57 papers
Top 3%
4.7%
6
PLOS ONE
based on 1737 papers
Top 73%
4.5%
7
British Journal of Cancer
based on 22 papers
Top 1%
2.8%
8
Scientific Reports
based on 701 papers
Top 56%
2.8%
9
Clinical Cancer Research
based on 22 papers
Top 2%
2.8%
10
International Journal of Cancer
based on 18 papers
Top 0.7%
2.4%
50% of probability mass above
11
JNCI: Journal of the National Cancer Institute
based on 13 papers
Top 0.6%
2.4%
12
Frontiers in Oncology
based on 34 papers
Top 4%
2.4%
13
JAMA Network Open
based on 125 papers
Top 8%
2.4%
14
JCO Precision Oncology
based on 11 papers
Top 0.9%
2.3%
15
Human Genetics and Genomics Advances
based on 39 papers
Top 0.9%
2.3%
16
Journal for ImmunoTherapy of Cancer
based on 14 papers
Top 1%
2.3%
17
International Journal of Radiation Oncology*Biology*Physics
based on 13 papers
Top 1%
2.2%
18
Proceedings of the National Academy of Sciences
based on 100 papers
Top 8%
1.6%
19
npj Precision Oncology
based on 14 papers
Top 2%
1.6%
20
Breast Cancer Research
based on 11 papers
Top 1.0%
1.3%
21
JCO Clinical Cancer Informatics
based on 14 papers
Top 3%
1.3%
22
Nature Genetics
based on 72 papers
Top 7%
1.2%
23
Leukemia
based on 11 papers
Top 1%
1.2%
24
Communications Biology
based on 36 papers
Top 3%
1.2%
25
BMC Cancer
based on 21 papers
Top 4%
0.8%
26
The American Journal of Human Genetics
based on 77 papers
Top 7%
0.8%
27
Nature
based on 58 papers
Top 9%
0.8%
28
Clinical Epigenetics
based on 21 papers
Top 3%
0.7%
29
Nature Medicine
based on 88 papers
Top 20%
0.7%
30
Journal of Clinical Investigation
based on 50 papers
Top 5%
0.7%